Seel, Regarding the 2 new drugs from PolyM. If C
Post# of 72440
Regarding the 2 new drugs from PolyM. If CTIX does any reformulating or tweaking, doesn't that mean you have to go back to square 1 as far as clinical trials go?
I thought the antibiotic B looked pretty good but the D drug looked like it had blood pressure problems in trials that would have to be addressed. I also thought B was a whole game changer for antibiotics with it's new MOA that would prevent tolerances to be built up against it. Anything you can add relating to this would be most appreciated.
Also, do you see the Kard/PolyM people being able to handle the tweaking of D with just general overview by Dr M of the whole process or do you think it would take Dr M to be on such a project continuously?
Bad day in Texas today. The most beautiful yellow lab (only 6 yrs old) that came here everyday, owned by my nephew, has to be put down Mon for cancer. Couldn't have asked for a sweeter or more beautiful dog. Still had the chest and stomach of a young pup. I was her favorite as I kept treats for her handy.